🔗 Permalink

Inventor profile of:

Peter-Colin Gregory

City:

Hannover

Country:

Germany

Published Applications:

Last publication date:

2019-09-12

Top Assignees for applications by Peter-Colin Gregory

The entities that hold a legal rights for patent applications filed by inventor Gregory Peter-Colin:

Solvay Pharmaceuticals GmbH 12 Hannover, Germany
NOVOZYMES A/S 10 Bagsvaerd, Denmark
NOVOZYMES, INC. 3 Davis, CA United States
Solvay Pharmaceutical GmbH 1 Hannover, Germany
Novozymes A/S 1 Bagsvaerd, Germany
Solvay Pharmaceuticals Hans-Boeckler 1 Hannover, Germany
Solvay Pharmaceuticals, Inc. 1 Hannover, Germany
Solvay Pharmaceuticalss GmbH 1 Hannover, Germany
Abbott Products GmbH 1 Hanover, Germany

Recent patent applications by Gregory Peter-Colin

Peter-Colin Gregory from Hannover, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-09-12

US20190275122A1

Human necessities

PHARMACEUTICAL COMPOSITIONS OF LIPASE-CONTAINING PRODUCTS, IN PARTICULAR OF PANCREATIN

#2 | 2015-07-30

US20150209414A1

Human necessities

Lipase variants for pharmaceutical use

#3 | 2014-10-09

US20140302000A1

Human necessities

PHARMACEUTICAL COMPOSITIONS OF LIPASE-CONTAINING PRODUCTS, IN PARTICULAR OF PANCREATIN

#4 | 2012-12-06

US20120308543A1

Human necessities

Lipase variants for pharmaceutical use

#5 | 2012-08-16

US20120207741A1

Human necessities

Enzymes For Pharmaceutical Use

#6 | 2011-06-30

US20110158976A1

Human necessities

Enzymes for pharmaceutical use

#7 | 2011-05-12

US20110110910A1

Chemistry; metallurgy

Proteases for Pharmaceutical Use

#8 | 2010-12-23

US20100322915A1

Chemistry; metallurgy

Protease variants for pharmaceutical use

#9 | 2010-06-03

US20100135978A1

Chemistry; metallurgy

Proteases for Pharmaceutical Use

#10 | 2010-02-11

US20100034797A1

Human necessities

Lipase variants for pharmaceutical use

#11 | 2009-04-23

US20090104126A1

Human necessities

Sulfamate Compounds and Uses Thereof

#12 | 2009-02-19

US20090047266A1

Chemistry; metallurgy

Lipases for Pharmaceutical Use

#13 | 2008-12-25

US20080317726A1

Chemistry; metallurgy

Proteases for Pharmaceutical Use

#14 | 2007-11-01

US20070254863A1

Human necessities

Use of CBx cannabinoid receptor modulators as potassium channel modulators

#15 | 2007-11-01

US20070254862A1

Human necessities

Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators

#16 | 2007-08-16

US20070191357A1

Human necessities

METHODS OF USING POTASSIUM CHANNEL INHIBITING COMPOUNDS

#17 | 2007-06-28

US20070149512A1

Chemistry; metallurgy

N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions

#18 | 2007-05-24

US20070117823A1

Chemistry; metallurgy

N-sulfamoyl-N′-benzopyranpiperidine compounds and uses thereof

#19 | 2005-11-24

US20050261292A1

Human necessities

Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditions

#20 | 2005-11-10

US20050250817A1

Human necessities

Pharmaceutical compositions of lipase-containing products, in particular of pancreation

#21 | 2005-09-08

US20050197386A1

Chemistry; metallurgy

Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them

#22 | 2005-08-16

US10758240

Trifluoroacetylalkyl-substituted phenyl, phenol and benzoyl compounds and related methods of treatment

#23 | 2005-06-30

US20050143441A1

Human necessities

Novel medical combination treatment of obesity involving 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity

#24 | 2005-05-12

US20050101585A1

Human necessities

Use of selective CB1-antagonists in medical treatments

InventorID:

929203 ⎘